Immuneering Stock Forum

$Immuneering (IMRX.US)$ Near-Term Milestone Expectations
IMM-1-104
•Initial data from at least one additional arm of the Phase 2a portion of the Company’s Phase 1/2a trial is expected by year end.
IMM-6-415
•Initial PK, PD and safety data from the Phase 1 portion of the Company’s Phase 1/2a trial is expected by year end.

$Immuneering (IMRX.US)$
14/11/2024 - 05:05
- Announced Positive Initial Data, Including Complete and Partial Responses, with IMM-1-104 in Combination with Chemotherapy in First-Line Pancreatic Cancer Patients -
Granted FDA Orphan Drug Designation for IMM-1-104 in the Treatment of Pancreatic Cancer and Fast Track Designation in First-line Pancreatic Cancer
Initial Data From At Least One Additional Arm of the Ph...

$Immuneering (IMRX.US)$ Immuneering: Expects Cash Runway to Be Sufficient to Fund Ops Into 4Q 2025 >IMRX

$Immuneering (IMRX.US)$ Immuneering (NASDAQ:IMRX) reported quarterly losses of $(0.49) per share which beat the analyst consensus estimate of $(0.56) by 12.5 percent.

$Immuneering (IMRX.US)$
I am trying through some sort of astroprojection to create an alliance a collection of projected realities that induce the stock to $15 to the point where it will be one day we all know it we all know it will be well past that point
In reality we are experiencing together
I see $15 coming very quickly. I'm lining with it. I'm seeing it. I'm not worrying about it. It's gonna happen. It's gonna happen very fast.
I'm lining with everything and pushing towards cancer research ...